Page URL: https://www.bionews.org.uk/page_92359

Making the most of genomics for health

24 May 2010
By Dr Philippa Brice
Head of Knowledge and Communications, PHG Foundation
Appeared in BioNews 559
In 2008, the UK House of Lords' Committee on Science and Technology held a Genomic Medicine inquiry to assess the current and future impact of genomic technologies on clinical practice. Many key individuals and organisations submitted evidence to this inquiry, which culminated in the production of a report in July 2009. This found that the rapid pace of development in genomic science called for a new strategy for genomic medicine, and made various recommendations, including that the Government should produce a new White Paper on this issue.

The official Government response to the report in December 2009 was somewhat vague, although it did commit to establishing a cross-departmental Human Genetics Strategy Group (HGSG) with responsibility for developing a vision for genomics in the NHS. Meanwhile, the PHG Foundation (Foundation for Genomics and Population Health) was leading an initiative to produce an independent expert response to the original House of Lords report, in collaboration with the Centre for Science and Policy (CSaP) at the University of Cambridge.

The PHG Foundation's mission is making science work for health; we are the leading UK centre for public health genomics, which is defined as the responsible and effective translation of genome-based knowledge for the benefit of population health. CSaP works to build relationships between policy makers and scientific experts. Together, we held a series of workshops for leading scientists, clinicians, policy makers and experts in ethics, law and social science to consider the issues.

Released on 18 May (and previewed exclusively in the Times newspaper), Genomic Medicine: An Independent Response to the House of Lords Science and Technology Committee Report sets out the recommendations of this group. It found that the original report failed adequately reflect the realities of genomics and health, placing too much emphasis on the prospects for predicting the risk of common diseases for individuals, whilst paying too little attention to the current opportunities to use existing and rapidly emerging genetic knowledge and technologies to improve services for the diagnosis and care for single gene disorders. Although genomics has increasing potential to offer better care for patients outside the traditional sphere of clinical genetics - including through the use of pharmacogenetic tests to improve the efficacy and safety of drug treatments and genetic tests to help identify rarer inherited forms of common diseases such as cancer - risk prediction based on genome profiling has very little utility for individuals.

The PHG Foundation Report makes twelve key recommendations for the strategic development of genomic medicine within the UK, including the need to develop new mechanisms for evaluating all forms of genetic tests and analyses; new IT and informatics systems to store and process genetic data; and new ethical guidelines covering the storage, access and use of genomic tests and data within medical services. Investment in translational research and development is also called for, along with appropriate efforts to educate and engage the public on the genuine risks and benefits of genomics for health.

The Report, which was delivered to members of the HGSG in advance of its inaugural meeting, is available from the PHG Foundation website.

SOURCES & REFERENCES
Centre for Science and Policy
University of Cambridge |  24 May 2010
Independent response to House of Lords Science and Technology Committee Genomic Medicine report
phg Foundation |  18 May 2010
Potential of genomic medicine could be lost, say science think-tanks
TimesOnline |  17 May 2010
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
11 April 2012 - by Dr Stuart Hogarth and Professor Brian Salter 
The Department of Health (DH) has announced the formation of a new body to advise on emerging healthcare scientific developments and their ethical, legal, social and economic implications. The new body, the Emerging Science and Bioethics Advisory Committee (ESBAC), will rise phoenix-like from the ashes of the Human Genetics Commission (HGC), which was incinerated in the government's recent bonfire of the quangos. It is a telling illustration of the continued governance challeng...
6 February 2012 - by Suzanne Elvidge 
The idea of whole genome sequencing is becoming ever more popular, but it could mean you end up with more information than you bargained for; from your resistance to certain drugs to your risk of developing a range of diseases. But would you want to know? The Wellcome Trust Sanger Institute ethics team has launched a survey to find out what people really do (and don't) want to know about their genomes...
31 October 2011 - by Dr Rebecca Robey 
The NHS must take steps to prepare for a revolution in genetics-based medicine, according to a new report by the independent think tank, the Foundation for Genomics and Public Health (the PHG Foundation). The Foundation says that rapid advances in technology will soon make it possible for individuals to have their entire genome analysed affordably, and this will have a major impact on many aspects of healthcare...
21 December 2009 - by Dr Rob Elles, Dr Frances Flinter and Dr Christine Patch 
The report from the UK House of Lords' Science and Technology Committee Inquiry into Genomic Medicine argued that rapid developments in genetic science require a new strategy for its delivery within health services and research. The Government's response to the Report largely restates past achievements and seems to suggest that minor modifications of current processes will allow delivery of the benefits of advances in knowledge....
20 July 2009 - by Sandy Starr 
From our perspective at the Progress Educational Trust (PET), one of the most welcome aspects of the House of Lords Science and Technology Committee's new report 'Genomic Medicine' is its consideration of public engagement issues. This section of the report appears to anticipate and complement PET's plans for its 2009 annual conference, entitled 'Does Genetics Matter? Help, Hype and the New Horizon of Epigenetics', which will take place in East London on Wednesday 18 November....
19 July 2009 - by Dr Rob Elles 
Since 2003, the framework for policy in Genetics in Medicine in the UK has been the Genetic White Paper 'Our Inheritance Our future.' There is no doubt that its implementation helped modernise and broaden the scope of genetics in the National Health Service (NHS). It developed new support structures including the National Genetics Education Development Centre and the National Genetic Reference Laboratories, and established the (short lived) Genetic Knowledge Parks....
9 July 2009 - by MacKenna Roberts 
When giving evidence to the Lords' inquiry into genomic medicine, Health Minister Dawn Primarolo estimated that the vast potential benefits of genomic medicine will not largely be seen by patients for at least a decade. The House of Lords Science and Technology Committee respectfully but conclusively disagrees in its report on Genomic Medicine, published 7 July 2009. Lord Patel who chaired the inquiry surmised; 'Genomic medicine will clearly have a huge impact on health provision and the NHS
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.